Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.6 USD | +0.80% | -0.30% | +18.18% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.18% | 323B | |
+32.51% | 690B | |
+26.43% | 546B | |
-4.96% | 358B | |
+5.12% | 287B | |
+14.30% | 235B | |
+5.77% | 199B | |
-9.41% | 195B | |
+4.87% | 161B | |
-1.92% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135